Journal of Clinical Pathways April 8, 2022
Jane Myles, vice president of clinical trial innovation, Curebase

Health care providers and public health officials in the United States are increasingly aware of the need to ensure health equity. When people of color and other underserved groups lack quality health care and nutrition, they experience poorer health outcomes, including chronic conditions and premature death. In addition to the human pain and suffering, health inequity costs the United States nearly $100 billion annually in excess medical spending.

But health equity is a global concern. Across the world there are people who cannot access or afford quality health care. In many countries, particularly in Africa and Southeast Asia, health inequity impacts much of the population. Even in relatively wealthy nations such as those in western Europe, tens of millions of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Equity/SDOH, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Trends
Researchers explore 9 more diseases GLP-1s could treat
Eli Lilly Shows Obesity Drug Zepbound Can Treat Sleep Apnea Too
Opinion: Even with new law, clinical trials lack data on older adults
Eli Lilly's tirzepatide scores again, this time in 2 sleep apnea trials
Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials

Share This Article